全文获取类型
收费全文 | 8795篇 |
免费 | 378篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 268篇 |
妇产科学 | 111篇 |
基础医学 | 336篇 |
口腔科学 | 83篇 |
临床医学 | 3068篇 |
内科学 | 769篇 |
皮肤病学 | 40篇 |
神经病学 | 257篇 |
特种医学 | 56篇 |
外科学 | 773篇 |
综合类 | 1061篇 |
预防医学 | 1333篇 |
眼科学 | 39篇 |
药学 | 631篇 |
9篇 | |
中国医学 | 149篇 |
肿瘤学 | 189篇 |
出版年
2024年 | 14篇 |
2023年 | 243篇 |
2022年 | 564篇 |
2021年 | 587篇 |
2020年 | 480篇 |
2019年 | 661篇 |
2018年 | 574篇 |
2017年 | 325篇 |
2016年 | 284篇 |
2015年 | 319篇 |
2014年 | 797篇 |
2013年 | 771篇 |
2012年 | 688篇 |
2011年 | 758篇 |
2010年 | 543篇 |
2009年 | 335篇 |
2008年 | 187篇 |
2007年 | 163篇 |
2006年 | 133篇 |
2005年 | 99篇 |
2004年 | 86篇 |
2003年 | 60篇 |
2002年 | 64篇 |
2001年 | 44篇 |
2000年 | 44篇 |
1999年 | 42篇 |
1998年 | 29篇 |
1997年 | 18篇 |
1996年 | 15篇 |
1995年 | 24篇 |
1994年 | 13篇 |
1993年 | 13篇 |
1992年 | 9篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1985年 | 34篇 |
1984年 | 39篇 |
1983年 | 20篇 |
1982年 | 19篇 |
1981年 | 14篇 |
1980年 | 16篇 |
1979年 | 10篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1973年 | 2篇 |
1972年 | 3篇 |
排序方式: 共有9190条查询结果,搜索用时 171 毫秒
1.
2.
3.
4.
目的通过Meta分析评价安宁疗护对社区临终患者生活质量的影响。方法计算机检索PubMed、CINAHL、ScienceDirect、MEDLINE、Cochrane Library、SAGE数据库、中国知网、维普中文科技期刊数据库、万方数据库和中国生物医学文献数据库中安宁疗护对社区临终患者的随机对照试验,由2名研究人员独立筛选文献并提取资料,对符合质量标准的随机对照试验进行Meta分析。结果共纳入7篇文献,包括1095名社区临终患者。Meta分析结果显示,安宁疗护可以改善社区临终患者的总体生活质量(SMD=0.48,95%CI0.07~0.88,P=0.02)和情绪功能(SMD=1.27,95%CI0.59~1.95,P<0.001),在改善生活质量的躯体功能、角色功能、认知功能和社会功能水平上差异无统计学意义(P>0.05)。结论安宁疗护能改善社区临终患者的总体生活质量和情绪功能,但对生活质量其他功能的改善情况还需要设计更加规范、多中心、大样本的随机对照试验进一步证实。 相似文献
5.
6.
《Neuro-Chirurgie》2022,68(3):262-266
BackgroundThe prognosis for patients with recurrent glioblastoma (GBM) is dismal, and the question of repeat surgery at time of recurrence is common. Re-operation in the management of these patients remains controversial, as there is no randomized evidence of benefit. An all-inclusive pragmatic care trial is needed to evaluate the role of repeat resection.Methods3rGBM is a multicenter, pragmatic, prospective, parallel-group randomized care trial, with 1:1 allocation to repeat resection or standard care with no repeat resection. To test the hypothesis that repeat resection can improve overall survival by at least 3 months (from 6 to 9 months), 250 adult patients with prior resection of pathology-proven glioblastoma for whom the attending surgeon believes repeat resection may improve quality survival will be enrolled. A surrogate measure of quality of life, the number of days outside of hospital/nursing/palliative care facility, will also be compared. Centers are invited to participate without financial compensation and without contracts. Clinicians may apply to local authorities to approve an investigator-led in-house trial, using a common protocol, web-based randomization platform, and simple standardized case report forms.DiscussionThe 3rGBM trial is a modern transparent care research framework with no additional risks, tests, or visits other than what patients would encounter in normal care. The burden of proof remains on repeat surgical management of recurrent GBM, because this management has yet to be shown beneficial. The trial is designed to help patients and surgeons manage the uncertainty regarding optimal care.Clinical Trial Registrationhttp://www.clinicaltrials.gov. Unique identifier: NCT04838782. 相似文献
7.
8.
Lauren Thaete 《Progress in Palliative Care》2019,27(1):10-13
Effective communication between clinicians, patients, and families at end of life is associated with better clinical outcomes. A large body of literature describes the key skills needed for effective communication. We believe that clinicians could also benefit from communication skills more commonly associated with business or law negotiations. We will demonstrate via analogy (i.e. buying a house) how four key business/law negotiation techniques – 1. Determine your Reservation and Aspiration Value; 2. Separate People from their Positions; 3. Separate Positions from Interests; and 4. Logrolling of Interests – can be applied to a difficult family meeting in a home hospice patient. 相似文献
9.
10.
ObjectiveThe purpose of this paper is to review the efficacy and safety profile in children treated with topical 0.03% Tacrolimus ointment for vernal keratoconjunctivitis in Middle East and to propose a treatment posology. According to recent studies, a complex non-IgE dependent mechanism plays a relevant role in the pathogenesis of vernal keratoconjunctivitis. Numerous cells and mediators have been found in the serum, conjunctiva and tears of patients with Vernal keratoconjunctivitis.DesignThis case series included 10 patients from a single centre, pediatric department of a tertiary hospital with active symptomatic vernal keratoconjunctivitis. All the patients had proliferative lesions and corneal involvement despite conventional medications, including topical steroids. All other medications, systemic and topical: steroids, antihistamines and cyclosporine, were unsuccessful. Patients were treated with topical 0.03% Tacrolimus ointment twice daily for 8 weeks and then once a day for the next two month followed by thrice a week for two months. The changes in symptoms and signs after treatment were evaluated, also the development of possible complications was assessed.ResultsThe results showed a significant reduction in signs and symptoms after 4 weeks of the treatment. Clinical resolution of giant papillae and corneal lesions were seen within eight weeks and no additional drug was required during that period, except tear substitutes. Treatment was continued for period of two months and then slowly reduced.ConclusionThe use of 0.03% Tacrolimus ointment is safe and effective in children refractory to conventional treatment of vernal keratoconjunctivitis even in high temperature climate as Middle East. Due to the effectiveness of the treatment, the dosage used may be proposed for conventional use. 相似文献